Eagle Pharmaceuticals Inc (EGRX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Eagle Pharmaceuticals, Inc. is on the clock to file its overdue quarterly report after receiving a delinquency notice from Nasdaq for not complying with listing rules. They’ve been granted a 180-day extension until May 13, 2024, to submit their financials and avoid delisting. The company’s future on the stock market hangs in the balance as they work to meet the deadline and maintain their listing status.
For further insights into EGRX stock, check out TipRanks’ Stock Analysis page.